HIVE DIGITAL TECHNOLOGIES LT (HIVE.CA) Stock Fundamental Analysis
Canada - TSX-V:HIVE - CA4339211035 - Common Stock
5.14 CAD
-1.35 (-20.8%)
HIVE gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 63 industry peers in the Software industry. The financial health of HIVE is average, but there are quite some concerns on its profitability. HIVE is not overvalued while it is showing excellent growth. This is an interesting combination.
1. Profitability
1.1 Basic Checks
In the past year HIVE was profitable.
HIVE had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: HIVE reported negative net income in multiple years.
In the past 5 years HIVE always reported a positive cash flow from operatings.
1.2 Ratios
Looking at the Return On Assets, with a value of 4.57%, HIVE is in the better half of the industry, outperforming 77.78% of the companies in the same industry.
The Return On Equity of HIVE (5.13%) is better than 69.84% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.57% | ||
| ROE | 5.13% | ||
| ROIC | N/A |
ROA(3y)-37.49%
ROA(5y)-16.27%
ROE(3y)-49.77%
ROE(5y)-22%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
Looking at the Profit Margin, with a value of 22.36%, HIVE belongs to the top of the industry, outperforming 95.24% of the companies in the same industry.
HIVE does not have Operating Margin and Gross Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | 22.36% | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
HIVE does not have a ROIC to compare to the WACC, probably because it is not profitable.
HIVE has more shares outstanding than it did 1 year ago.
The number of shares outstanding for HIVE has been increased compared to 5 years ago.
Compared to 1 year ago, HIVE has an improved debt to assets ratio.
2.2 Solvency
HIVE has an Altman-Z score of 9.18. This indicates that HIVE is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of HIVE (9.18) is better than 85.71% of its industry peers.
A Debt/Equity ratio of 0.03 indicates that HIVE is not too dependend on debt financing.
With a decent Debt to Equity ratio value of 0.03, HIVE is doing good in the industry, outperforming 74.60% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.03 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 9.18 |
ROIC/WACCN/A
WACC10.03%
2.3 Liquidity
A Current Ratio of 3.42 indicates that HIVE has no problem at all paying its short term obligations.
The Current ratio of HIVE (3.42) is better than 84.13% of its industry peers.
HIVE has a Quick Ratio of 3.42. This indicates that HIVE is financially healthy and has no problem in meeting its short term obligations.
HIVE's Quick ratio of 3.42 is amongst the best of the industry. HIVE outperforms 84.13% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.42 | ||
| Quick Ratio | 3.42 |
3. Growth
3.1 Past
HIVE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 145.17%, which is quite impressive.
HIVE shows a small growth in Revenue. In the last year, the Revenue has grown by 4.47%.
The Revenue has been growing by 31.59% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)145.17%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%500%
Revenue 1Y (TTM)4.47%
Revenue growth 3Y-18.07%
Revenue growth 5Y31.59%
Sales Q2Q%41.47%
3.2 Future
The Earnings Per Share is expected to grow by 78.85% on average over the next years. This is a very strong growth
Based on estimates for the next years, HIVE will show a very strong growth in Revenue. The Revenue will grow by 53.13% on average per year.
EPS Next Y737.89%
EPS Next 2Y432.1%
EPS Next 3Y78.85%
EPS Next 5YN/A
Revenue Next Year189.49%
Revenue Next 2Y101.53%
Revenue Next 3Y53.13%
Revenue Next 5YN/A
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 28.56 indicates a quite expensive valuation of HIVE.
Based on the Price/Earnings ratio, HIVE is valued cheaper than 80.95% of the companies in the same industry.
When comparing the Price/Earnings ratio of HIVE to the average of the S&P500 Index (25.91), we can say HIVE is valued inline with the index average.
With a Price/Forward Earnings ratio of 7.34, the valuation of HIVE can be described as very cheap.
Based on the Price/Forward Earnings ratio, HIVE is valued cheaply inside the industry as 84.13% of the companies are valued more expensively.
HIVE is valuated cheaply when we compare the Price/Forward Earnings ratio to 34.57, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 28.56 | ||
| Fwd PE | 7.34 |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
HIVE's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as HIVE's earnings are expected to grow with 78.85% in the coming years.
PEG (NY)0.04
PEG (5Y)N/A
EPS Next 2Y432.1%
EPS Next 3Y78.85%
5. Dividend
5.1 Amount
No dividends for HIVE!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
TSX-V:HIVE (11/13/2025, 7:00:00 PM)
5.14
-1.35 (-20.8%)
Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)
Earnings (Next)
Inst Owners23.03%
Inst Owner ChangeN/A
Ins Owners0.29%
Ins Owner ChangeN/A
Market Cap1.22B
Revenue(TTM)128.65M
Net Income(TTM)28.76M
Analysts80
Price Target6.63 (28.99%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)185.32%
Min EPS beat(2)100.9%
Max EPS beat(2)269.73%
EPS beat(4)4
Avg EPS beat(4)130.87%
Min EPS beat(4)43.42%
Max EPS beat(4)269.73%
EPS beat(8)7
Avg EPS beat(8)88.66%
EPS beat(12)9
Avg EPS beat(12)16.46%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)0.88%
Min Revenue beat(2)-1.52%
Max Revenue beat(2)3.29%
Revenue beat(4)2
Avg Revenue beat(4)-0.05%
Min Revenue beat(4)-8.08%
Max Revenue beat(4)6.13%
Revenue beat(8)5
Avg Revenue beat(8)3.67%
Revenue beat(12)9
Avg Revenue beat(12)18.5%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)6.12%
PT rev (3m)13.04%
EPS NQ rev (1m)6.25%
EPS NQ rev (3m)54.55%
EPS NY rev (1m)2.85%
EPS NY rev (3m)349.94%
Revenue NQ rev (1m)4.99%
Revenue NQ rev (3m)14.87%
Revenue NY rev (1m)0.84%
Revenue NY rev (3m)10.54%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 28.56 | ||
| Fwd PE | 7.34 | ||
| P/S | 6.77 | ||
| P/FCF | N/A | ||
| P/OCF | 28.54 | ||
| P/B | 1.55 | ||
| P/tB | 1.55 | ||
| EV/EBITDA | N/A |
EPS(TTM)0.18
EY3.5%
EPS(NY)0.7
Fwd EY13.63%
FCF(TTM)-0.7
FCFYN/A
OCF(TTM)0.18
OCFY3.5%
SpS0.76
BVpS3.31
TBVpS3.31
PEG (NY)0.04
PEG (5Y)N/A
Graham Number3.66
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.57% | ||
| ROE | 5.13% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | 22.36% | ||
| GM | N/A | ||
| FCFM | N/A |
ROA(3y)-37.49%
ROA(5y)-16.27%
ROE(3y)-49.77%
ROE(5y)-22%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.2
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.03 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 206.22% | ||
| Cap/Sales | 116.51% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 3.42 | ||
| Quick Ratio | 3.42 | ||
| Altman-Z | 9.18 |
F-Score5
WACC10.03%
ROIC/WACCN/A
Cap/Depr(3y)97.27%
Cap/Depr(5y)157.57%
Cap/Sales(3y)54.64%
Cap/Sales(5y)58.11%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)145.17%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%500%
EPS Next Y737.89%
EPS Next 2Y432.1%
EPS Next 3Y78.85%
EPS Next 5YN/A
Revenue 1Y (TTM)4.47%
Revenue growth 3Y-18.07%
Revenue growth 5Y31.59%
Sales Q2Q%41.47%
Revenue Next Year189.49%
Revenue Next 2Y101.53%
Revenue Next 3Y53.13%
Revenue Next 5YN/A
EBIT growth 1Y-98.15%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year350.81%
EBIT Next 3Y65.08%
EBIT Next 5YN/A
FCF growth 1Y-313.96%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-33.66%
OCF growth 3Y-36.92%
OCF growth 5Y84.91%
HIVE DIGITAL TECHNOLOGIES LT / HIVE.CA FAQ
Can you provide the ChartMill fundamental rating for HIVE DIGITAL TECHNOLOGIES LT?
ChartMill assigns a fundamental rating of 5 / 10 to HIVE.CA.
What is the valuation status of HIVE DIGITAL TECHNOLOGIES LT (HIVE.CA) stock?
ChartMill assigns a valuation rating of 5 / 10 to HIVE DIGITAL TECHNOLOGIES LT (HIVE.CA). This can be considered as Fairly Valued.
Can you provide the profitability details for HIVE DIGITAL TECHNOLOGIES LT?
HIVE DIGITAL TECHNOLOGIES LT (HIVE.CA) has a profitability rating of 3 / 10.
What is the earnings growth outlook for HIVE DIGITAL TECHNOLOGIES LT?
The Earnings per Share (EPS) of HIVE DIGITAL TECHNOLOGIES LT (HIVE.CA) is expected to grow by 737.89% in the next year.